Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 4 of 4

Full-Text Articles in Medicine and Health Sciences

Cost Effectiveness Of Treating Generalized Anxiety Disorder In Adolescence: A Comparison By Provider Type And Therapy Modality, Kathryn Evelyn Reynolds Dec 2014

Cost Effectiveness Of Treating Generalized Anxiety Disorder In Adolescence: A Comparison By Provider Type And Therapy Modality, Kathryn Evelyn Reynolds

Theses and Dissertations

Generalized anxiety disorder (GAD) is frequently found in primary care settings and is highly prevalent among adolescents. The purpose of this study was to examine the cost effectiveness by provider type and therapy modality in treating adolescents (ages 13-17) with a GAD diagnosis (DSM-IV 300.02). A national insurance company in the United States provided outpatient and unidentifiable data for adolescent GAD cases (n = 2,932). These cases were used to analyze the cost effectiveness, total cost, treatment length, dropout, and readmission rates for the treatment of adolescents with GAD. Descriptive statistics signify that the mean cost of treatment for GAD …


Impact Of Universal Disinfectant Cap Implementation On Central Line–Associated Bloodstream Infections, Katreena Collette Merrill, Sharon Sumner, Lorraine Linford, Carrie Taylor, Christopher Macintosh Nov 2014

Impact Of Universal Disinfectant Cap Implementation On Central Line–Associated Bloodstream Infections, Katreena Collette Merrill, Sharon Sumner, Lorraine Linford, Carrie Taylor, Christopher Macintosh

Faculty Publications

Background: Central line–associated bloodstream infections (CLABSIs) result in increased length of stay, cost, and patient morbidity and mortality. One CLABSI prevention method is disinfection of intravenous access points. The literature suggests that placing disinfectant caps over needleless connectors decreases CLABSI risk.

Methods: A quasi-experimental intervention study was conducted in a >430-bed trauma I center. In addition to an existing standard central line bundle, a new intervention consisting of a luer-lock disinfectant cap with 70% alcohol was implemented in all intravenous (IV) needleless connectors on patients with peripheral and central lines. Compliance to the disinfectant cap was monitored weekly. A generalized …


Treatment Outcomes For Mood Disorders With Concurrent Partner Relational Distress: A Comparison By Treatment Modality And Profession, Holly Pack Jul 2014

Treatment Outcomes For Mood Disorders With Concurrent Partner Relational Distress: A Comparison By Treatment Modality And Profession, Holly Pack

Theses and Dissertations

Mood disorders are often linked with concurrent partner relational distress. The present study compared the cost effectiveness of treating mood disorder alone versus when the condition is comorbid with partner relational distress. Cigna, a leading health insurance management company in the US, provided outpatient data. Participants included patients with solely a mood disorder diagnosis (n = 72,712) and those with both a mood disorder and a comorbid partner relational distress diagnosis (n = 113, including 69 females and 44 males). These participants were treated in outpatient settings throughout the US. These numbers are surprisingly low considering the extensive literature showing …


Attention Deficit Hyperactivity Disorder: Comparison Of Medication Efficacy And Cost, Robert M. David, Karlen E. Luthy, Janelle L. B. Macintosh, Lacey M. Eden Jun 2014

Attention Deficit Hyperactivity Disorder: Comparison Of Medication Efficacy And Cost, Robert M. David, Karlen E. Luthy, Janelle L. B. Macintosh, Lacey M. Eden

Student Works

Although a common psychological disorder, pharmacological treatment of Attention Deficit Hyperactivity Disorder can be a costly endeavor. Among 4-5 year olds, methylphenidate is a safe, efficacious, and cost-effective option for short-, intermediate-, and long-acting medication options. Short-acting methylphenidate, intermediate-acting methylphenidate ER and SR, and long-acting methylphenidate LA are the most efficacious and cost-effective medications. Selection of non-stimulant medications should be based upon recommended guidelines rather than primarily on cost. For children incapable of swallowing pills, the most efficacious and cost-effective treatments are short-acting dextroamphetamine liquid and long-acting methylphenidate LA capsules that can be opened and sprinkled over food.